Simplifying Global Compliance
Articles Tagged with ''Daily International Pharma Alert''
Sanofi-aventis announced that Swissmedic, the Swiss agency for therapeutic products, has approved the company's weight-loss drug Acomplia. Read More
Australia's Department of Health and Ageing has posted a draft version of the Australian Therapeutic Products Bill on its website for consultation. Read More
Beximco Pharmaceuticals announced it has begun supplying generic drugs to Ghana. Read More
Impax Laboratories announced it has signed an agreement with Purdue Pharma and certain of its affiliates to settle patent infringement litigation pertaining to Impax's generic versions of Purdue's OxyContin. Read More
Roche has expanded its preclinical drug-discovery platforms with a $56.5 million acquisition of Therapeutic Human Polyclonals (THP), the Swiss drugmaker said. Read More
Indian drugmaker Ranbaxy Laboratories has announced that, as part of its collaboration agreement with GlaxoSmithKline (GSK), the companies have selected a compound to develop for the treatment of respiratory inflammation. Read More
South Africa's National AIDS Council, in its capacity as the country coordinator for the Global Fund to fight AIDS, Tuberculosis (TB) and Malaria, has called on organizations to submit proposals for the seventh round of funding. Read More
Novartis will stop selling its constipation drug Zelnorm because of an increased risk of serious adverse cardiovascular events, the FDA announced. Read More
The European Medicines Agency (EMEA) has recommended restrictions on the use of sanofi-aventis' antibiotic Ketek for three of its four approved indications. Read More
Japanese drugmaker Takeda Pharmaceutical has announced several new drug-development agreements. Read More
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing